ATBECHDEDKESFRGBGRITLILUNL..MCPTIE......FI..........................................................JDIM360 Ver 2.15 (14 Jul 2008) - 2999001/00812593CORRECTED NEW EUROPEAN PATENT SPECIFICATIONB8B220101110W184deBibliographieenBibliographyfrBibliographieEP97101617.5199403141997042819981208enenen930602919930323GB940341719940223GB20101110201045199712171997512001082920013520010414200106122008010220080120101110201045A61K 39/39 20060101AFI20010710BHEP de3-0-Deazylierte Monophosphoryl Lipid A enthaltende Impfstoff-ZusammensetzungenenVaccine compositions containing 3-0 deacylated monophosphoryl lipid afrCompositions vaccinales renfermant de lipide A monophosphorylique 3-0-desacétyléEP-A- 0 339 667WO-A-86/01826WO-A-92/11291WO-A-92/16231WO-A-92/16556WO-A-93/19780WO-A-94/19013INFECTION AND IMMUNITY, vol. 51, no. 3, March 1986, WASHINGTON D.C.,USA, pages 784-787, XP002039957 COURSAGET ET AL: "SIMULTANEOUS ADMINISTRATION OF DIPHTHERIA-TETANUS-PERTUSSIS-POLIO AND HEPATITIS B VACCINES IN A SIMPLIFIED IMMUNIZATION PROGRAM:IMMUNE RESPONSE TO DIPHTHERIA TOXOID,TETANUS TOXOID,PERTUSSIS,AND HEPATITIS B SURFACE ANTIGEN"94911894.706894541994092901112703.2117591220010525Hauser, PierreSmithKline Beecham, 89 rue de l'Institut1330 RixensartBEVoet, PierreSmithKline Beecham, 89 rue de l'Institut1330 RixensartBESlaoui, MoncefSmithKline Beecham, 89 rue de l'Institut1330 RixensartBEGarcon-Johnson, Nathalie Marie-Josephe ClaudeSmithKline Beecham, 89 rue de l'Institut1330 RixensartBEDesmons, PierreSmithKline Beecham, 89 rue de l'Institut1330 RixensartBESmithKline Beecham Biologicals S.A.100223289RLE/B45042 DIV189 rue de l'Institut1330 RixensartBEDalton, Marcus Jonathan Williamet al100028966GlaxoSmithKline Corporate Intellectual Property (CN9.25.1) 980 Great West RoadBrentford, Middlesex TW8 9GSGB01200205290American Cyanamid Company100699739Five Giralda FarmsMadison, New Jersey 07940USMannion, Sally Kim100030201Wyeth Laboratories Huntercombe Lane SouthTaplow Maidenhead Berkshire SL6 0PHGBATBECHDEDKESFRGBGRIEITLILUMCNLPT19971217199751